Show simple item record

Authordc.contributor.authorDucasse, Karen 
Authordc.contributor.authorFernández, José P. es_CL
Authordc.contributor.authorSalgado Muñoz, Carmen es_CL
Authordc.contributor.authorÁlvarez, Ana M. es_CL
Authordc.contributor.authorAvilés, Carmen L. es_CL
Authordc.contributor.authorBecker, Ana es_CL
Authordc.contributor.authorTopelberg, Santiago es_CL
Authordc.contributor.authorTordecilla Cadiu, Juan es_CL
Authordc.contributor.authorVaras P., Mónica es_CL
Authordc.contributor.authorVillarroel, Milena es_CL
Authordc.contributor.authorViviani, Tamara es_CL
Authordc.contributor.authorZubieta, Marcela es_CL
Authordc.contributor.authorSantolaya de Pablo, María Elena es_CL
Admission datedc.date.accessioned2014-12-31T02:15:01Z
Available datedc.date.available2014-12-31T02:15:01Z
Publication datedc.date.issued2014
Cita de ítemdc.identifier.citationRev Chilena Infectol 2014; 31 (3): 333-338en_US
Identifierdc.identifier.issn0716-1018
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/129509
General notedc.descriptionArtículo de publicación SciELOen_US
Abstractdc.description.abstractLeukemia is the most common cancer in Chilean children. Acute lymphoblastic leukemia (ALL) is more prevalent and longer survival compared to acute myeloid leukemia (AML). Aims: To describe episodes of febrile neutropenia (FN) in children with AML, determining frequency of infections as agent, focus and evolution, comparing children with ALL episodes. Method: A prospective multicenter study. Children presenting with FN at six hospitals in Santiago, Chile, were invited to participate in two consecutive FONDECYT projects, from April 2004 to June 2011. All patients were uniformly evaluated, recording epidemiological, clinical and laboratory variables. Information regarding FN episodes of children with LMA and LLA was used to this study. Results: We evaluated 506 episodes of FN in children with leukemia: 173 children with AML and 333 in children with ALL. NF episodes in children with AML showed significantly greater depth and duration of neutropenia, febrile remained a > period of time and had a worse clinical outcome, as evidenced by > hemodynamic instability, > sepsis, CRP > 90 mg/L for a longer time, more days of hospitalization, > frequency of hospitalization in ICU, > bacteremia, mainly by Streptococcus viridans group, > change of antimicrobial treatment, > use of antifungal therapy. Conclusions: This study demonstrates that FN episodes in children with AML further evolve unfavorably, compared with episodes of FN in children with ALL. FN episodes in children with AML require a more aggressive diagnostic and therapeutic approach, related to its severity.en_US
Patrocinadordc.description.sponsorshipFinanciado por FONDECYT 1040907, 1090194en_US
Lenguagedc.language.isoesen_US
Publisherdc.publisherSociedad Chilena de Infectologíaen_US
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectleukemiaen_US
Títulodc.titleCaracterización de los episodios de neutropenia febril en niños con leucemia mieloide aguda y leucemia linfoblástica agudaen_US
Title in another languagedc.title.alternativeCharacterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile